Top Markets
Coin of the day
Lin BioScience, Inc. Lin BioScience, Inc.

Lin BioScience, Inc.

6696
株式のランク #5730
Lin BioScience, Inc. is an innovative biopharmaceutical company focused on... Lin BioScience, Inc. is an innovative biopharmaceutical company focused on developing novel therapies across oncology, ophthalmology, and metabolic diseases. Its robust pipeline includes LBS-008, an orally administered treatment currently in Phase 3 clinical trials for adolescent Stargardt disease (STGD1) and Phase 2/3 trials for dry age-related macular degeneration (Dry AMD), both aimed at evaluating its safety and effectiveness. Other key candidates are LBS-007, a natural non-ATP CDC7 inhibitor designed to combat various cancers; LBS-002, an anti-tubulin compound targeting primary and metastatic brain tumors; and LBS-009, an oral medication for non-alcoholic fatty liver disease and Type 2 diabetes. The company is headquartered in Taipei, Taiwan.
株価
$29.86
最終同期: 2026-08-19
時価総額
$2.48B
変化(1日)
4.92%
変化(1年)
502.82%
TW
取引 Lin BioScience, Inc. (6696)

カテゴリー

Lin BioScience, Inc.(6696)の株価履歴
終値の最高値: $26.88 (2026-08-01)

終値の最安値: $1.30 (2018-10-01)
Lin BioScience, Inc. の株価履歴(2018 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -3.77%
2025 202.95%
2024 13.59%
2023 -31.65%
2022 -22.82%
2021 101.12%
2020 278.57%
2019 -21.27%
2018 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$543.30 39.64%
US
$1.05K 47.66%
NL
$122.63 -12.65%
AU
$144.26 474.74%
US
$761.61 6.68%
CH